Investigational Site Number : 2500001

Marseille 13885

1 studies enrolling now · 3 studies all time

What they study most

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Immunoglobulin G4 Related Disease, Non-small Cell Lung Cancer Metastatic

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients — Stopped early
• Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Completed